CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma

CD133 is a marker of stem cells as well cancer stem cells. This study investigated the association between CD133 expression in cancer cells and the clinical outcome of non-mucin producing intrahepatic cholangiocarcinoma (ICC).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cai, Xiao Bo (VerfasserIn) , Yuan, Xiaodong (VerfasserIn) , Dooley, Steven (VerfasserIn) , Weng, Honglei (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 06 March 2018
In: Journal of translational medicine
Year: 2018, Jahrgang: 16, Pages: 1-7
ISSN:1479-5876
DOI:10.1186/s12967-018-1423-9
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12967-018-1423-9
Volltext
Verfasserangaben:Xiaobo Cai, Jun Li, Xiaodong Yuan, Jingbo Xiao, Steven Dooley, Xinjian Wan, Honglei Weng and Lungen Lu
Beschreibung
Zusammenfassung:CD133 is a marker of stem cells as well cancer stem cells. This study investigated the association between CD133 expression in cancer cells and the clinical outcome of non-mucin producing intrahepatic cholangiocarcinoma (ICC).
Beschreibung:Gesehen am 08.06.2020
Beschreibung:Online Resource
ISSN:1479-5876
DOI:10.1186/s12967-018-1423-9